Search

everythinglearnresearchcommunity

for

Search:↓

A new method accurately measures nine neuroactive steroids in small blood samples, helping to study brain diseases.

Hair steroid profiling is a feasible, non-invasive alternative to serum analysis for assessing hormone levels and metabolism.

Women with Polycystic Ovary Syndrome (PCOS) have lower levels of a substance called DIAPH1 in their blood, which is linked to changes in sugar metabolism and insulin resistance.

More body hair in young Australian women is linked to higher androstenedione levels.

Higher prolactin levels are linked to psoriasis, alopecia areata, and vitiligo severity.

Melatonin receptors in hair follicles help regulate hair growth and could treat hair loss.

BMP4 helps stem cells turn into pigment-producing cells, affecting hair color and growth.

PSA might help diagnose PCOS and related skin issues, but more research is needed.

Minoxidil can reduce functions related to androgen receptors.

Higher doses of glucocorticoids increase the risk of blood clots in asthma patients.

Drugs for hormone-related conditions might help treat mental disorders but could have serious side effects.

The research suggests that autophagy-related genes might play a role in causing alopecia areata.

Dutasteride and finasteride can help increase hair growth gene expression but need further improvement.

Flutamide effectively reduced excessive hair growth and improved related symptoms in hirsutism patients without significant side effects.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Most pregnancies with SLE resulted in intrauterine growth restriction (IUGR).

Thyrotropin-releasing hormone may help control skin and hair growth and could aid in treating related disorders.

Sex hormones affect hair growth and loss, and treatments for related hair diseases include various medications, hair transplantation, and light therapy.

Skin problems can be signs of hormone-related disorders and recognizing them early is important for treatment.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

The method accurately measures steroid hormones in hair to study hormone dynamics related to hair loss.

Losing weight and eating better are key to managing metabolic syndrome and its related conditions.

Early diagnosis and surgery are crucial for managing cryptorchidism and related hair loss in dogs.

The document suggests treating individuals with nonclassic congenital adrenal hyperplasia who show symptoms, especially those related to excess male hormones.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

The chapter explains the causes of excessive hair growth and masculinization in women and how to measure hormone levels related to these conditions.

Satoyoshi syndrome is likely an autoimmune disease that mainly affects young women and improves with immune-related treatments.

The document concludes that while there are promising methods to control CRISPR/Cas9 gene editing, more research is needed to overcome challenges related to safety and effectiveness for clinical use.

Hormones significantly affect hair and oil gland function in the skin, and more research is needed on skin-related hormone disorders.